Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulation of the Sense of Agency Across Different Neurological Disorders Using Non-invasive Brain Stimulation and Mindfulness-based Stress Reduction Therapy

NCT05086380 is registered in ClinicalTrials.gov with University of Fribourg as lead sponsor.

NCT NCT05086380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05086380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulation of the Sense of Agency Across Different Neurological Disorders Using Non-invasive Brain Stimulation and Mindfulness-based Stress Reduction Therapy
Lead sponsor
University of Fribourg
Phase
Not applicable
Overall status
Completed
Start date
December 10, 2021
Completion date
December 16, 2024
Enrollment
190 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

functional neurological symptom disorder, neurological diseases or conditions